CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Medical Coverage Policy Intravitreal and Punctum Corticosteroid Implants

This document section contains references, citations, and administrative disclaimers related to the medical coverage policy for intravitreal and punctum corticosteroid implants. It does not contain specific coverage criteria or billing rules in this part.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyMedical Coverage Policy Intravitreal and Punctum Corticosteroid Implants

Policy CodePolicy N/A

Change TypeReferences and administrative disclaimer only

Effective Date10/01/2015

Next Review Date

Key ActionRefer to the references, citations, and administrative disclaimer in this section and consult the member's Evidence of Coverage or Subscriber Agreement for benefit determinations.

SourceLink

POLICY UPDATE CHANGES

This section contains only references, citations, and administrative disclaimers; no material clinical/coverage changes are noted.

References onlyContent Type

~20Referenced studies

Scope & Purpose

This document section contains references, citations, and administrative disclaimers related to the medical coverage policy for Intravitreal and Punctum Corticosteroid Implants (references and disclaimers). It does not contain specific coverage criteria or billing rules in this part.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

References & Administrative Disclaimer

This part of the policy contains the literature references (PMIDs, journal citations) supporting the policy and an administrative disclaimer that the policy does not substitute for clinical judgment and that member benefits are determined by subscriber agreements.

~20 referenced studies listed (references 72-91 and others).

Reference	Citation / PMID
No results

Operational Notes for Providers

Note

References and Disclaimers (no coverage criteria here)

This section contains the literature references and administrative disclaimers related to the medical policy for intravitreal and punctum corticosteroid implants. It does not include coverage criteria, clinical requirements, or billing rules. Providers should consult the full medical policy for specific clinical coverage criteria and any prior authorization or billing requirements that apply to patient care.